PANHEPRIN Side Effects

5836842-5 | Diarrhoea, Dysuria, Erythema, Headache, Nausea, Rash
on Jul 31, 2008 Female patient from UNITED STATES , 55 years of age, weighting 260.0 lb, was diagnosed with cellulitis (What is cellulitis?) and was treated with Panheprin (View Usage). Patient experienced the following unwanted or unexpected effects: diarrhoea, dysuria, erythema, headache (What is headache?), nausea (What is nausea?), rash (What is rash?). Panheprin dosage: Bid, Intravenous Heparin Lock. During the same period patient was treated with SALINE (SODIUM CHLORIDE) (View Saline (sodium Chloride) Review and Saline (sodium Chloride) Label ), ANTIBIOTIC (ANTIBIOTICS) (View Antibiotic (antibiotics) Review and Antibiotic (antibiotics) Label ).

5778548-7 | Heart Rate Decreased, Hyperhidrosis, Pallor, Palpitations
Patient was taking Panheprin (View Usage). Patient had the following side effects: heart rate decreased, hyperhidrosis, pallor, palpitations on Feb 21, 2008 from UNITED STATES Additional patient health information: Male patient , 62 years of age, was diagnosed with central venous catheterisation and. Panheprin dosage: 5 Ml, Once, Injection. During the same period patient was treated with SALINE (SODIUM CHLORIDE) (View Saline (sodium Chloride) Review and Saline (sodium Chloride) Label ).

5778545-1 | Pyrexia
Adverse event was reported on Dec 20, 2007 by a Male patient taking Panheprin (View Usage) (Dosage: 3 Ml, Prn, Intravenous) . Location: UNITED STATES , weighting 132.0 lb, After Panheprin was administered, patient had the following side effects: pyrexia. During the same period patient was treated with SALINE FLUSH (SODIUM CHLORIDE) (View Saline Flush (sodium Chloride) Review and Saline Flush (sodium Chloride) Label ), TOBRAMYCIN (View Tobramycin Review and Tobramycin Label ).

5760693-3 | Anaphylactic Reaction, Body Temperature Increased, Chest Pain, Cyanosis, Hypotension, Sepsis
on May 30, 2008 Male patient from UNITED STATES , 40 years of age, weighting 194.0 lb, was diagnosed with intravenous catheter management and was treated with Panheprin (View Usage). Patient experienced the following unwanted or unexpected effects: anaphylactic reaction, body temperature increased, chest pain (What is chest pain?), cyanosis, hypotension, sepsis (What is sepsis?). Panheprin dosage: . During the same period patient was treated with LORCET (VICODIN) (View Lorcet (vicodin) Review and Lorcet (vicodin) Label ), ULTRAM (View Ultram Review and Ultram Label ), KLONOPIN (View Klonopin Review and Klonopin Label ).


5746489-7 | Chest Discomfort, Clonus, Convulsion, Cyanosis, Dizziness, Dyspnoea, Grand Mal Convulsion, Malaise, Unresponsive To Stimuli
on May 13, 2008 Female patient from UNITED STATES , 30 years of age, was diagnosed with intravenous catheter management and was treated with Panheprin (View Usage). Patient had the following side effects: chest discomfort, clonus, convulsion, cyanosis, dizziness (What is dizziness?), dyspnoea, grand mal convulsion, malaise, unresponsive to stimuli. Panheprin dosage: 100 Unit, Peripherally Inserted Central Catheter.

5745299-4 | Anaphylactic Reaction, Sepsis
Patient was taking Panheprin (View Usage). After Panheprin was administered, patient had the following side effects: anaphylactic reaction, sepsis (What is sepsis?) on May 13, 2008 from UNITED STATES Additional patient health information: Male patient , 40 years of age, weighting 194.0 lb, was diagnosed with intravenous catheter management and. Panheprin dosage: . During the same period patient was treated with LORCET (VICODIN) (View Lorcet (vicodin) Review and Lorcet (vicodin) Label ), ULTRAM (View Ultram Review and Ultram Label ), KLONOPIN (View Klonopin Review and Klonopin Label ).

5734937-8 | Cyanosis, Dyspnoea, Grand Mal Convulsion, Unresponsive To Stimuli
Adverse event was reported on May 01, 2008 by a Female patient taking Panheprin (View Usage) (Dosage: 100 Unit, Peripherally Inserted Central Catheter) was diagnosed with central venous catheterisation and. Location: UNITED STATES , 30 years of age, Patient experienced the following unwanted or unexpected effects: cyanosis, dyspnoea, grand mal convulsion, unresponsive to stimuli.

5730340-5 | Anaphylactic Reaction
on Apr 30, 2008 Male patient from UNITED STATES , 63 years of age, weighting 180.0 lb, was diagnosed with flushing and was treated with Panheprin (View Usage). Patient had the following side effects: anaphylactic reaction. Panheprin dosage: Once, Picc Line. Patient was hospitalized.

5714713-2 | Abdominal Pain Upper, Diarrhoea, Dysphagia, Dyspnoea, Headache, Hyperhidrosis, Tachycardia, Vomiting
on Apr 15, 2008 Male patient from UNITED STATES , 56 years of age, was diagnosed with intravenous catheter management and was treated with Panheprin (View Usage). After Panheprin was administered, patient had the following side effects: abdominal pain upper, diarrhoea, dysphagia, dyspnoea, headache (What is headache?), hyperhidrosis, tachycardia, vomiting. Panheprin dosage: Once A Day, Intravenous. During the same period patient was treated with PERCOCET (View Percocet Review and Percocet Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ), FLAGYL (View Flagyl Review and Flagyl Label ), WELLBUTRIN (View Wellbutrin Review and Wellbutrin Label ), SINGULAIR (View Singulair Review and Singulair Label ).

5711379-2 | Blood Pressure Decreased, Cold Sweat, Depressed Level Of Consciousness, Dizziness, Feeling Abnormal, Headache
Patient was taking Panheprin (View Usage). Patient experienced the following unwanted or unexpected effects: blood pressure decreased, cold sweat, depressed level of consciousness, dizziness (What is dizziness?), feeling abnormal, headache (What is headache?) on Apr 10, 2008 from UNITED STATES Additional patient health information: Female patient , 55 years of age, weighting 337.0 lb, was diagnosed with central venous catheterisation and. Panheprin dosage: 100 Mg Units/ml, Flush, Intravenous. During the same period patient was treated with VANCOMYCIN (View Vancomycin Review and Vancomycin Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ), BUPIVACAINE 0.25% (BUPIVACAINE) (View Bupivacaine 0.25% (bupivacaine) Review and Bupivacaine 0.25% (bupivacaine) Label ), CLINDAMYCIN HCL (View Clindamycin Hcl Review and Clindamycin Hcl Label ), FENTANYL (View Fentanyl Review and Fentanyl Label ), DEXAMETHASONE TAB (View Dexamethasone Tab Review and Dexamethasone Tab Label ), PREDNISONE TAB (View Prednisone Tab Review and Prednisone Tab Label ), PRIMAXIN (View Primaxin Review and Primaxin Label ).

5711321-4 | Convulsion, Cyanosis, Nausea, Respiratory Arrest
Adverse event was reported on Apr 10, 2008 by a Male patient taking Panheprin (View Usage) (Dosage: 100 Mg Units/ml, Flush, Intravenous) was diagnosed with central venous catheterisation and. Location: UNITED STATES , 42 years of age, weighting 394.0 lb, Patient had the following side effects: convulsion, cyanosis, nausea (What is nausea?), respiratory arrest. During the same period patient was treated with BENADRYL (View Benadryl Review and Benadryl Label ), ZOFRAN (View Zofran Review and Zofran Label ), 0.9% NACL (SODIUM CHLORIDE) (View 0.9% Nacl (sodium Chloride) Review and 0.9% Nacl (sodium Chloride) Label ), VANCOMYCIN (View Vancomycin Review and Vancomycin Label ), HEPARIN (View Heparin Review and Heparin Label ).

5702860-0 | Convulsion, Nausea, Respiratory Arrest
on Apr 02, 2008 Female patient from UNITED STATES , 42 years of age, weighting 394.0 lb, was diagnosed with therapeutic procedure and was treated with Panheprin (View Usage). After Panheprin was administered, patient had the following side effects: convulsion, nausea (What is nausea?), respiratory arrest. Panheprin dosage: 100 Units/ml, Flush, Intravenous. During the same period patient was treated with BENADRYL (View Benadryl Review and Benadryl Label ), ZOFRAN (View Zofran Review and Zofran Label ), 0.9% NACL(SODIUM CHLORIDE) (View 0.9% Nacl(sodium Chloride) Review and 0.9% Nacl(sodium Chloride) Label ), VANCOMYCIN (View Vancomycin Review and Vancomycin Label ), HEPARIN (View Heparin Review and Heparin Label ).

5702857-0 | Blood Pressure Decreased, Cold Sweat, Depressed Level Of Consciousness, Feeling Abnormal
on Apr 02, 2008 Female patient from UNITED STATES , 55 years of age, weighting 337.0 lb, was diagnosed with therapeutic procedure and was treated with Panheprin (View Usage). Patient experienced the following unwanted or unexpected effects: blood pressure decreased, cold sweat, depressed level of consciousness, feeling abnormal. Panheprin dosage: 100 Units/ml, Flush, Intravenous. During the same period patient was treated with VANCOMYCIN (View Vancomycin Review and Vancomycin Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ), BUPIVACAINE 0.25% (BUPIVACAINE) (View Bupivacaine 0.25% (bupivacaine) Review and Bupivacaine 0.25% (bupivacaine) Label ), CLINDAMYCIN HCL (View Clindamycin Hcl Review and Clindamycin Hcl Label ), FENTANYL (View Fentanyl Review and Fentanyl Label ), DEXAMETHASONE TAB (View Dexamethasone Tab Review and Dexamethasone Tab Label ), PREDNISONE TAB (View Prednisone Tab Review and Prednisone Tab Label ), PRIMAXIN (View Primaxin Review and Primaxin Label ).

5699401-3 | Chest Discomfort, Dyspnoea, Hypotension, Oxygen Saturation Decreased, Tachycardia, Urticaria, Wheezing
Patient was taking Panheprin (View Usage). Patient had the following side effects: chest discomfort, dyspnoea, hypotension, oxygen saturation decreased, tachycardia, urticaria, wheezing on Mar 28, 2008 from UNITED STATES Additional patient health information: Female patient , weighting 189.6 lb, was diagnosed with indwelling catheter management and. Panheprin dosage: 5ml (500 Units), Once, Intravenous.

5656205-5 | Dyspnoea, Hypersensitivity, Pruritus, Urticaria
Adverse event was reported on Feb 21, 2008 by a Male patient taking Panheprin (View Usage) (Dosage: 300 Unit, Every 8 Hrs And As Needed, Intravenous) was diagnosed with central venous catheterisation and. Location: UNITED STATES , 62 years of age, weighting 262.0 lb, After Panheprin was administered, patient had the following side effects: dyspnoea, hypersensitivity, pruritus, urticaria. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), BUMETANIDE (View Bumetanide Review and Bumetanide Label ), CARVEDILOL (View Carvedilol Review and Carvedilol Label ), ENOXAPARIN SODIUM (View Enoxaparin Sodium Review and Enoxaparin Sodium Label ), PANTOPRAZOLE SODIUM (View Pantoprazole Sodium Review and Pantoprazole Sodium Label ), POTASSIUM CHLORIDE (View Potassium Chloride Review and Potassium Chloride Label ), ALDACTONE (View Aldactone Review and Aldactone Label ), CLARITIN (View Claritin Review and Claritin Label ).